In Normandy, two childhood friends gave birth to a revolution in the field of MedTech. Arterya, with its innovative device Blood’Up, redefines arterial detection, transforming the medical world with cutting-edge technology dedicated to optimizing blood sampling. Under the direction of Lucile Derly, this Caen start-up is preparing to mark a decisive turning point in healthcare establishments, by combining passion for innovation and the quest for efficiency. An adventure imbued with modernity where the arteries are highlighted thanks to a unique solution, revealing the promise of simplified and precise care.
Arterya Biography: A Revolution in Medtech
In the constantly evolving field of medtech, Arterya stands out as a beacon of innovation, pushing the boundaries of what is possible in the medical sector. This Normandy startup, built on the dreams and determination of Nicodème Pellier, aspiring surgeon, and Lucile Derly, embodies the spirit of French ingenuity. Arterya is focused on a clear mission: transforming and improving the efficiency of care through advanced technologies.
At the heart of this ambition is the Blood’Up, a revolutionary medical device that promises to simplify blood sampling on a global scale. With its unique immediate artery detection system, this product has the potential to redefine the way healthcare professionals approach care procedures, alleviating stress for patients and caregivers.
By positioning itself on a B2B and B2G market, Arterya ensures that its innovations are integrated into healthcare establishments, thus proving that innovation can be a powerful lever for change for everyone. Arterya thus embodies the perfect intersection between passion, technicality and change, defying expectations and strengthening the journey of the healthtech towards a brighter future.
birth of arterya
Arterya was born from the imagination and audacity of two enthusiasts, Nicodème Pellier and Lucile Derly, who decided to combine their talents to transform the scene medical with bold innovations. Uniting their visions and expertise, they founded this start-up in March 2021 with the conviction that the technology can offer new horizons for health. Their motivation was to revolutionize sampling blood with the Blood’Up, a device that predicts a significant transformation in the field.
The history of Arterya is also that of a dynamic region, Normandy, already recognized for its potential in the field ofinnovation medical. Supported by the local ecosystem, the founders set out to create a unique solution like the Blood’Up, allowing instantaneous detection of arteries. This breakthrough was born from a simple but brilliant observation of a failure in current sampling practice, paving the way for this major invention.
technology development
The development of Arterya was marked by meticulous research and pioneering engineering which culminated in the launch of the <>, designed to revolutionize current sampling methods. This remarkable medical device highlights an innovative feature of instant artery detection, which offers unprecedented efficiency to healthcare establishments. Thanks to the Blood’Up, arterial sampling becomes simple and accurate, thereby not only reducing patient anxiety, but also improving the performance of healthcare practitioners.
This product is the result of a long journey of research and development, with iterative testing and support from experts in health to optimize its performance. By getting a foot in the door for the B2B and B2G market with its invention, Arterya aims to extend its possible applications on a larger scale. Innovation is not only limited to clinical precision, but also embraces a technological approach to make medical processes more reliable and accessible.
impacts and future prospects
Arterya’s potential goes well beyond simple technical innovations in the field of health. This start-up is a living example of how a bold and well-thought-out idea can redefine existing standards. Their approach has been recognized by many industry experts across Normandy and beyond, highlighting a notable breakthrough in the sector medtech.
Arterya continues to enrich its technological portfolio and explore new avenues for improvement. Their innovations, as relayed on platforms like Maddyness, demonstrate their ability to reinvent traditional medical practices. With the momentum gained and a product as promising as the Blood’Up, Arterya aspires, ultimately, to completely transform healthcare through technology, keeping people at the heart of their approach, thus paving the way for even more innovations on the horizon.
